|
A new path to hope
Brainsgate is a medical device company committed to developing a novel treatment modality, electrical SPG stimulation. This platform technology has been shown to increase blood flow to the brain and as a result has broad potential for treating central nervous system disorders. BrainsGate is currently focusing on:
1. Improve the outcome of patients suffering from ischemic stroke, in a 24 hour window after onset of symptoms. 2. Long-term SPG stimulation for the treatment of vascular dementia patients.
 |
Focus: ISS
BrainsGate's product for the treatment of ischemic stroke and vascular dementia
read more |
 |
Focus: the spheno-palatine ganglion
Two small nervous centers located above the roof of the mouth near the sinuses
read more |
|
May 26, 2011
ImpACT-24b Trial Launch
BrainsGate launches the ImpACT-24b at the European Stroke Conference 2011 in Hamburg > full story
January 3, 2011
President Shimon Peres visits BrainsGate
BrainsGate was proud to host the President of the State of Israel and a Nobel Peace Prize laureate, Mr. Shimon Peres, in its Caesarea headquarters. > full story
|